GB9521987D0 - Phosphoinositide 3-kinase modulators - Google Patents

Phosphoinositide 3-kinase modulators

Info

Publication number
GB9521987D0
GB9521987D0 GBGB9521987.9A GB9521987A GB9521987D0 GB 9521987 D0 GB9521987 D0 GB 9521987D0 GB 9521987 A GB9521987 A GB 9521987A GB 9521987 D0 GB9521987 D0 GB 9521987D0
Authority
GB
United Kingdom
Prior art keywords
phosphoinositide
kinase modulators
modulators
kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9521987.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Priority to GBGB9521987.9A priority Critical patent/GB9521987D0/en
Publication of GB9521987D0 publication Critical patent/GB9521987D0/en
Priority to AU73182/96A priority patent/AU7318296A/en
Priority to PCT/GB1996/002614 priority patent/WO1997015658A1/en
Pending legal-status Critical Current

Links

GBGB9521987.9A 1995-10-26 1995-10-26 Phosphoinositide 3-kinase modulators Pending GB9521987D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9521987.9A GB9521987D0 (en) 1995-10-26 1995-10-26 Phosphoinositide 3-kinase modulators
AU73182/96A AU7318296A (en) 1995-10-26 1996-10-28 Wortmannin phosphoinositide 3-kinase interaction site
PCT/GB1996/002614 WO1997015658A1 (en) 1995-10-26 1996-10-28 Wortmannin phosphoinositide 3-kinase interaction site

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9521987.9A GB9521987D0 (en) 1995-10-26 1995-10-26 Phosphoinositide 3-kinase modulators

Publications (1)

Publication Number Publication Date
GB9521987D0 true GB9521987D0 (en) 1996-01-03

Family

ID=10782966

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9521987.9A Pending GB9521987D0 (en) 1995-10-26 1995-10-26 Phosphoinositide 3-kinase modulators

Country Status (3)

Country Link
AU (1) AU7318296A (en)
GB (1) GB9521987D0 (en)
WO (1) WO1997015658A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
US7049313B2 (en) 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
CA2534300A1 (en) 2003-08-13 2005-02-24 Kudos Pharmaceuticals Limited Aminopyrones and their use as atm inhibitors
JP2008513428A (en) 2004-09-20 2008-05-01 クドス ファーマシューティカルズ リミテッド DNA-PK inhibitor
US9512125B2 (en) 2004-11-19 2016-12-06 The Regents Of The University Of California Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
WO2006085067A1 (en) 2005-02-09 2006-08-17 Kudos Pharmaceuticals Limited Atm inhibitors
AR053358A1 (en) 2005-04-15 2007-05-02 Cancer Rec Tech Ltd DNA INHIBITORS - PK
EA019961B1 (en) * 2006-04-04 2014-07-30 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Kinase antagonists
EP2402347A1 (en) 2006-04-26 2012-01-04 F. Hoffmann-La Roche AG Pharmaceutical compounds
EP2114949A1 (en) 2006-12-07 2009-11-11 F.Hoffmann-La Roche Ag Phosphoinositide 3-kinase inhibitor compounds and methods of use
DK2222675T3 (en) 2007-12-19 2013-11-04 Genentech Inc 5-ANILINOIMIDAZOPYRIDINES AND PROCEDURES FOR THEIR USE
KR20100099185A (en) 2007-12-21 2010-09-10 제넨테크, 인크. Azaindolizines and methods of use
WO2010006072A2 (en) 2008-07-08 2010-01-14 The Regents Of The University Of California Mtor modulators and uses thereof
US8476282B2 (en) 2008-11-03 2013-07-02 Intellikine Llc Benzoxazole kinase inhibitors and methods of use
WO2010091150A1 (en) 2009-02-05 2010-08-12 Immunogen, Inc. Novel benzodiazepine derivatives
WO2010105008A2 (en) 2009-03-12 2010-09-16 Genentech, Inc. Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
WO2011022439A1 (en) 2009-08-17 2011-02-24 Intellikine, Inc. Heterocyclic compounds and uses thereof
EP2483277B1 (en) 2009-09-28 2015-12-02 F. Hoffmann-La Roche AG Benzoxepin pi3k inhibitor compounds and methods of use
US8980899B2 (en) 2009-10-16 2015-03-17 The Regents Of The University Of California Methods of inhibiting Ire1
WO2011049625A1 (en) 2009-10-20 2011-04-28 Mansour Samadpour Method for aflatoxin screening of products
AU2010316780B2 (en) 2009-11-05 2015-07-16 Rhizen Pharmaceuticals Sa Novel benzopyran kinase modulators
WO2011100403A1 (en) 2010-02-10 2011-08-18 Immunogen, Inc Cd20 antibodies and uses thereof
EP3053600B1 (en) 2011-02-15 2020-01-29 ImmunoGen, Inc. Cytotoxic benzodiazepine derivatives
ES2710874T3 (en) 2011-05-04 2019-04-29 Rhizen Pharmaceuticals S A Novel compounds as modulators of protein kinases
AU2012341028C1 (en) 2011-09-02 2017-10-19 Mount Sinai School Of Medicine Substituted pyrazolo[3,4-D]pyrimidines and uses thereof
CN104470923B (en) 2012-07-04 2019-03-29 理森制药股份公司 Selective PI3K δ inhibitor
EP2887965A1 (en) 2012-08-22 2015-07-01 ImmunoGen, Inc. Cytotoxic benzodiazepine derivatives
KR20150061651A (en) 2012-09-26 2015-06-04 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 Modulation of ire1
JP6494533B2 (en) 2013-02-28 2019-04-03 イミュノジェン・インコーポレーテッド Complexes comprising maytansinoids as cell binding agents and cytotoxic agents
JP6423804B2 (en) 2013-02-28 2018-11-14 イミュノジェン・インコーポレーテッド Complex containing cell binding agent and cytotoxic agent
CN105209042B (en) 2013-03-22 2019-03-08 米伦纽姆医药公司 The combination of 1/2 inhibitor of catalytic MTORC and selective aurora A kinase inhibitor
WO2014194030A2 (en) 2013-05-31 2014-12-04 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
EP3507305A1 (en) 2016-09-02 2019-07-10 Dana-Farber Cancer Institute, Inc. Composition and methods of treating b cell disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9208135D0 (en) * 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
US5525503A (en) * 1993-09-28 1996-06-11 Dana-Farber Cancer Institute, Inc. Signal transduction via CD28
CA2133815A1 (en) * 1993-10-12 1995-04-13 Jeffrey Alan Dodge Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
JP3471879B2 (en) * 1994-01-20 2003-12-02 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ Method for inhibiting serine kinase activity, method for adjusting binding activity between PI3-kinase subunits, PI3-kinase subunit binding antibody, hybridoma cell line producing this antibody, nucleic acid molecule, plasmid, agonist, antagonist, PI3-kinase Subunit binding molecule that inhibits kinase activity, method for detecting presence of subunit, method for producing inhibitor of PI3-kinase activity, and inhibitor for PI3-kinase activity

Also Published As

Publication number Publication date
WO1997015658A1 (en) 1997-05-01
AU7318296A (en) 1997-05-15

Similar Documents

Publication Publication Date Title
GB9521987D0 (en) Phosphoinositide 3-kinase modulators
AP9701021A0 (en) Novel compounds
GB9507203D0 (en) Novel compounds
IL116659A0 (en) Flange
GB9510051D0 (en) Integrated optical modulators
IL117886A0 (en) Switched-inverter modulator
GB9507811D0 (en) Novel photoinitiators
ZA968451B (en) Novel sulfonylaminopyrimidines
DE69601083D1 (en) Passiver akusto-optischer modulator
GB2308487B (en) CD-Player
AU3379295A (en) Hand-operated signal generator
GB2306773B (en) Optical modulator
GB2305512B (en) Optical modulator
GB2315129B (en) Integrated optical modulators
GB9507593D0 (en) Novel pad
GB2321340B (en) Optical modulator
GB9515224D0 (en) Novel instrument
GB9502915D0 (en) Hydrogel adhesives
GB9503193D0 (en) Optical modulator
GB9516005D0 (en) Novel catalyst
GB9503206D0 (en) Novel use
ZA9610639B (en) Polymerization
GB9503647D0 (en) Novel compounds
GB9503177D0 (en) Novel compounds
GB9520151D0 (en) Novel compounds